Home/Filings/4/0001022079-25-000233
4//SEC Filing

Davis J. E. 4

Accession 0001022079-25-000233

CIK 0001022079other

Filed

Nov 27, 7:00 PM ET

Accepted

Nov 28, 4:30 PM ET

Size

12.6 KB

Accession

0001022079-25-000233

Insider Transaction Report

Form 4
Period: 2025-11-25
Davis J. E.
SVP, Operations
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-25$95.80/sh+55,093$5,277,634175,573 total
  • Sale

    Common Stock

    2025-11-25$191.59/sh9,342$1,789,823166,231 total
  • Sale

    Common Stock

    2025-11-25$192.27/sh41,004$7,883,901125,227 total
  • Sale

    Common Stock

    2025-11-25$192.97/sh4,747$916,037120,480 total
  • Exercise/Conversion

    Non-Qualifed Stock Option (right to buy)

    2025-11-25$95.80/sh55,093$5,277,6340 total
    Exercise: $95.80Exp: 2027-02-21Common Stock (55,093 underlying)
Footnotes (5)
  • [F1]This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
  • [F2]This transaction was executed in multiple trades at prices ranging from $190.810 to $191.805. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $191.820 to $192.810. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $192.820 to $193.310. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.

Issuer

QUEST DIAGNOSTICS INC

CIK 0001022079

Entity typeother

Related Parties

1
  • filerCIK 0001599837

Filing Metadata

Form type
4
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 4:30 PM ET
Size
12.6 KB